Published in J Clin Endocrinol Metab on February 01, 1996
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2010) 4.95
X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis (2012) 2.28
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2016) 1.43
X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry (1997) 1.09
The importance of testing for adrenoleucodystrophy in males with idiopathic Addison's disease. Arch Dis Child (2002) 0.84
Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis. CMAJ (2004) 0.83
Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's disease. BMJ Case Rep (2012) 0.80
Childhood adrenoleukodystrophy - Classic and variant - Review of clinical manifestations and magnetic resonance imaging. J Pediatr Neurosci (2013) 0.78
Twenty years of dysuria in a patient with Addison's disease: a case report. Cases J (2009) 0.75
Clinical reasoning: a 56-year-old man with progressive spasticity. Neurology (2013) 0.75
Therapeutic strategies in adrenoleukodystrophy. Wien Med Wochenschr (2017) 0.75
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature (1993) 5.05
Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98
Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension (2000) 1.87
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86
Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med (1993) 1.83
Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab (1999) 1.78
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab (1998) 1.68
Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab (1998) 1.63
Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med (1973) 1.62
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol (Oxf) (2000) 1.60
Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol (1999) 1.59
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol (1999) 1.55
Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes. Diabetologia (2000) 1.53
Influence of respiratory instability during neurocardiogenic presyncope on cerebrovascular and cardiovascular dynamics. Heart (2007) 1.49
The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet (1994) 1.47
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care (1996) 1.46
Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab (1999) 1.45
Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia (1995) 1.42
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. J Clin Endocrinol Metab (2004) 1.39
Adrenoleucodystrophy: dermatological findings and skin surface lipid study. Dermatology (1994) 1.39
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem (1999) 1.39
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J (2003) 1.30
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
A 195-kb cosmid walk encompassing the human Xq28 color vision pigment genes. Genomics (1990) 1.28
Effects of whole-body vibration exercise on the endocrine system of healthy men. J Endocrinol Invest (2004) 1.23
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21
Genomic organization of the adrenoleukodystrophy gene. Genomics (1994) 1.19
Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol (2000) 1.18
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev (2005) 1.18
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med (2005) 1.17
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care (1997) 1.17
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation (1999) 1.15
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab (2005) 1.15
High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab (1995) 1.14
Demonstration of a dawn phenomenon in normal human volunteers. Diabetes (1984) 1.10
The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci (1999) 1.09
Abnormal messenger RNA expression and a missense mutation in patients with X-linked adrenoleukodystrophy. Hum Mol Genet (1993) 1.07
Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care (1998) 1.05
Pancreatic alpha-cell function in trauma. JAMA (1974) 1.05
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. Oncogene (2006) 1.02
Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract (1994) 1.01
Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels. Diabetologia (1980) 1.01
The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett (1994) 1.01
Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab (2000) 1.00
Enoyl-CoA hydratase deficiency: identification of a new type of D-bifunctional protein deficiency. Hum Mol Genet (1999) 1.00
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes (1997) 1.00
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J Inherit Metab Dis (2007) 0.99
Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes (1993) 0.99
Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause. Gynecol Obstet Invest (1997) 0.98
Capillary gas-liquid chromatographic-mass spectrometric measurement of very long chain (C22 to C26) fatty acids in microliter samples of plasma. J Lipid Res (1985) 0.98
Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases. Acta Neuropathol (1999) 0.97
Suppressive effect of secretin upon pancreatic alpha cell function. J Clin Invest (1972) 0.97
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1988) 0.97
Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis. J Lab Clin Med (1973) 0.97
Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am J Hum Genet (1996) 0.97
A simulation study on a self-tuning portable controller of blood glucose. Int J Artif Organs (1993) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care (1993) 0.96
Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest (1997) 0.95
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. J Endocrinol Invest (2011) 0.95
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest (1992) 0.95
The cerebro-hepato-renal (Zellweger) syndrome: lamellar lipid profiles in adrenocortical, hepatic mesenchymal, astrocyte cells and increased levels of very long chain fatty acids and phytanic acid in the plasma. J Neurol Sci (1985) 0.95
Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transpl Immunol (2004) 0.95
Neonatal adrenoleukodystrophy. J Neurol Neurosurg Psychiatry (1986) 0.94
Contribution of cortisol to glucose counterregulation in humans. Am J Physiol (1989) 0.94
Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res (1990) 0.93
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. Clin Endocrinol (Oxf) (2007) 0.93